Non-anesthesiologist-administered Propofol During the Flexible Bronchoscopy

NACompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Conscious Sedation Failure During Procedure
Interventions
DEVICE

Transcutaneous CO2 monitor

Measurement and surveillance of transcutaneous CO2 pressure (PtcCO2) to determine PtcCO2 behavior for each sedation group.

DRUG

Midazolam

The initial dose was 0.05 mg/kg. Additional doses of 2 mg of midazolam were allowed to reach a score level of three to four in the Observer´s assessment of alertness/ sedation scale.

DRUG

Propofol

The initial dose was 0.1 mg /kg. Additional doses of 10 mg of propofol were allowed to reach a score level of three to four in the Observer´s assessment of alertness/ sedation scale.

DRUG

Nalbuphine

The starting dose was 2 mg with additional doses of 1 mg if it was necessary.

DRUG

Lidocaine

Lidocaine spray was applied to the nasal mucosa and pharynx for bronchoscope nostril insertion, and only in the pharynx for bronchoscope oral insertion. Topical lidocaine was applied using the spray-as-you-go technique, at a maximum dose of 7 mg/kg.

Trial Locations (1)

64000

UANL University Hospital, Monterrey

All Listed Sponsors
lead

Hospital Universitario Dr. Jose E. Gonzalez

OTHER

NCT02820051 - Non-anesthesiologist-administered Propofol During the Flexible Bronchoscopy | Biotech Hunter | Biotech Hunter